Defective immune surveillance in viral carcinogenesis.
D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology; D000818:Animals; D000917:Antibody Formation; D000951:Antigens, Neoplasm / Q000276:immunology*; D002051:Burkitt Lymphoma / Q000276:immunology; D002869:Chromosome Aberrations / Q000276:immunology; D025063:Chromosome Disorders; D004267:DNA Viruses / Q000276:immunology; D017977:Deltaretrovirus / Q000276:immunology; D006564:Herpesviridae / Q000276:immunology; D004854:Herpesvirus 4, Human / Q000276:immunology; D006716:Homosexuality; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000151:congenital / Q000235:genetics; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008223:Lymphoma / Q000139:chemically induced; D009858:Oncogenic Viruses / Q000276:immunology*; D011120:Polyomavirus / Q000276:immunology; D012190:Retroviridae / Q000276:immunology; D014178:Translocation, Genetic; D014412:Tumor Virus Infections / Q000276:immunology*
D000951:Antigens, Neoplasm; D007166:Immunosuppressive Agents